Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Papillary thyroid carcinoma.

I D Hay1

  • 1Mayo Medical School, Rochester, Minnesota.

Endocrinology and Metabolism Clinics of North America
|September 1, 1990
PubMed
Summary
This summary is machine-generated.

This study identifies key prognostic factors for papillary thyroid carcinoma in 1500 patients over 16 years. It details survival rates and discusses novel risk stratification and treatment controversies for better patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of radioactive iodine in the management of patients with differentiated thyroid cancer - An oncologic surgical perspective.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2020
Same author

Pediatric endocrine surgery: a 20-year experience at the Mayo Clinic.

The Journal of clinical endocrinology and metabolism·2014
Same author

[Papillary thyroid carcinoma: clinical manifestations, recurrences and prognosis].

Vestnik khirurgii imeni I. I. Grekova·2006
Same author

Percutaneous ethanol injection for treatment of cervical lymph node metastases in patients with papillary thyroid carcinoma.

AJR. American journal of roentgenology·2002
Same author

Anaplastic thyroid carcinoma: a 50-year experience at a single institution.

Surgery·2001
Same author

Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: correlation with radioiodine uptake.

The Journal of clinical endocrinology and metabolism·2001
Same journal

Adrenal Disorders in Pregnancy.

Endocrinology and metabolism clinics of North America·2026
Same journal

Diagnosis and Management of Adrenocortical Carcinoma.

Endocrinology and metabolism clinics of North America·2026
Same journal

Pheochromocytomas and Paragangliomas.

Endocrinology and metabolism clinics of North America·2026
Same journal

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.

Endocrinology and metabolism clinics of North America·2026
Same journal

Primary Bilateral Macronodular Adrenal Hyperplasia.

Endocrinology and metabolism clinics of North America·2026
Same journal

Evaluation and Management of Primary Aldosteronism.

Endocrinology and metabolism clinics of North America·2026
See all related articles

Area of Science:

  • Oncology
  • Endocrinology
  • Surgical Pathology

Background:

  • Papillary thyroid carcinoma (PTC) management involves understanding prognostic factors for patient outcomes.
  • Accurate prognostication is crucial for tailoring treatment strategies and predicting recurrence and mortality.

Purpose of the Study:

  • To identify and describe prognostic factors influencing outcomes in a large cohort of papillary thyroid carcinoma patients.
  • To evaluate novel prognostic scoring/staging systems and the utility of DNA ploidy testing.
  • To review controversies in surgical resection extent and radioiodine remnant ablation efficacy.

Main Methods:

  • Analysis of survival rates (recurrence, cause-specific mortality) in 1500 consecutive PTC patients.
  • Development and application of novel prognostic scoring or staging systems.

Related Experiment Videos

  • Review of existing literature on surgical extent and radioiodine remnant ablation.

    • Main Results:

    • Identification of multiple significant prognostic factors for PTC.
    • Description of long-term survival rates for tumor recurrence and cause-specific mortality.
    • Evaluation of risk groups based on new scoring systems and DNA ploidy results.

    Conclusions:

    • Prognostic factors significantly impact papillary thyroid carcinoma outcomes.
    • Novel staging systems and DNA ploidy may refine risk stratification.
    • Ongoing debate exists regarding optimal surgical and radioiodine treatment strategies.